Market Research Report
North America Advanced Wound Care Management Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||1010095|
|Published||Content info||166 Pages
Delivery time: 2-3 business days
|North America Advanced Wound Care Management Market Forecast 2021-2028|
|Published: June 14, 2021||Content info: 166 Pages||
The North America advanced wound care management market is anticipated to register a CAGR of 11.43% during the forecasting years. The regional market's growth is driven by factors such as the easy accessibility to wound care products, the availability of advanced healthcare facilities with trained medical professionals, the surging cases of road and sports accidents, and the increasing incidence of chronic conditions like obesity as well as diabetes.
The North America advanced wound care management market growth assessment entails the analysis of Canada and the United States. The annual cost of wound care in Canada is $4.5 billion. Despite the substantial expenditure, limited investment has been observed in the country, especially for the development of a wound care strategy for advanced healthcare management. Moreover, as per Wounds Canada, the nation lacks standardization in terms of selecting an appropriate healthcare provider for wound identification and management.
Leading players across the Canadian healthcare industry are innovating a strategy to convince healthcare decision-makers about the need for advanced practices in wound care. This measure would provide added clarity to the fact that compromised wounds are a co-condition of several common diseases, including diabetes, cancer, and cardiovascular disease. Moreover, 1.7% of patients admitted to hospitals following traumatic injuries or post-surgical procedures are likely to develop surgical site infections or pressure ulcers, thereby bolstering the demand for advanced wound care. Thus, these factors are projected to drive the North America advanced wound care management market over the forecasting period.
Prominent companies operating in the market are 3M Company, Adynxx Inc, Johnson & Johnson, Integra Lifesciences Holdings Corporation, etc.